Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Travis

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
BMJ Open Gastroenterology|February 9, 2024
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trialVipul Jairath, Guangyong Zou, Zhongya Wang, et al.
Journal of Crohn'S & Colitis|January 10, 2016
Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative ColitisVipul Jairath, Guangyong Zou, Claire E Parker, et al.
Inflammatory Bowel Diseases|May 12, 2011
Development of the Crohn's disease digestive damage score, the Lémann scoreBenjamin Pariente, Jacques Cosnes, Silvio Danese, et al.
Nature Genetics|June 15, 2007
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21David A van Heel, Lude Franke, Karen A Hunt, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Journal of Crohn'S & Colitis|December 3, 2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situationsGert Van Assche, Axel Dignass, Walter Reinisch, et al.
Human Molecular Genetics|September 12, 2015
Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrheaAndreas R Janecke, Peter Heinz-Erian, Jianyi Yin, et al.
Hepatology (Baltimore, Md.)|November 8, 2019
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based ApproachGuohong Han, Sarah Berhane, Hidenori Toyoda, et al.
Gut|November 1, 2016
Development of an index to define overall disease severity in IBDCorey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, et al.
Health Technology Assessment (Winchester, England)|February 17, 2026
Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn's disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort studyShankar Kumar, Andrew Plumb, Sue Mallett, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
BMJ Open Gastroenterology|February 9, 2024
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trialVipul Jairath, Guangyong Zou, Zhongya Wang, et al.
Journal of Crohn'S & Colitis|January 10, 2016
Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative ColitisVipul Jairath, Guangyong Zou, Claire E Parker, et al.
Inflammatory Bowel Diseases|May 12, 2011
Development of the Crohn's disease digestive damage score, the Lémann scoreBenjamin Pariente, Jacques Cosnes, Silvio Danese, et al.
Nature Genetics|June 15, 2007
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21David A van Heel, Lude Franke, Karen A Hunt, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Journal of Crohn'S & Colitis|December 3, 2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situationsGert Van Assche, Axel Dignass, Walter Reinisch, et al.
Human Molecular Genetics|September 12, 2015
Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrheaAndreas R Janecke, Peter Heinz-Erian, Jianyi Yin, et al.
Hepatology (Baltimore, Md.)|November 8, 2019
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based ApproachGuohong Han, Sarah Berhane, Hidenori Toyoda, et al.
Gut|November 1, 2016
Development of an index to define overall disease severity in IBDCorey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, et al.
Health Technology Assessment (Winchester, England)|February 17, 2026
Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn's disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort studyShankar Kumar, Andrew Plumb, Sue Mallett, et al.
Pageof 17